Exact Mass: 663.3605

Exact Mass Matches: 663.3605

Found 99 metabolites which its exact mass value is equals to given mass value 663.3605, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

KOdiA-PC

1-Palmitoyl-2-(5-keto-6-octenedioyl)-sn-glycero-3-phosphocholine

C32H58NO11P (663.3747)


   

didemniserinolipid B

didemniserinolipid B

C33H61NO10S (663.4016)


   
   
   

cyclo(-Leu1-Pro2-Leu3-Trp4-Pro5-Gly6-)|gypsin A

cyclo(-Leu1-Pro2-Leu3-Trp4-Pro5-Gly6-)|gypsin A

C35H49N7O6 (663.3744)


   

Ile Phe Asp Arg Asn

Ile Phe Asp Arg Asn

C29H45N9O9 (663.334)


   

Arg Val Phe Asp Lys

Arg Val Phe Asp Lys

C30H49N9O8 (663.3704)


   
   

Phe Arg Arg Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-5-carbamimidamidopentanamido]-5-carbamimidamidopentanamido]-3-(1H-indol-3-yl)propanoic acid

C32H45N11O5 (663.3605)


   

Phe Arg Trp Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-5-carbamimidamidopentanamido]-3-(1H-indol-3-yl)propanamido]-5-carbamimidamidopentanoic acid

C32H45N11O5 (663.3605)


   

Phe Trp Arg Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-(1H-indol-3-yl)propanamido]-5-carbamimidamidopentanamido]-5-carbamimidamidopentanoic acid

C32H45N11O5 (663.3605)


   

Arg Phe Arg Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-phenylpropanamido]-5-carbamimidamidopentanamido]-3-(1H-indol-3-yl)propanoic acid

C32H45N11O5 (663.3605)


   

Arg Phe Trp Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-phenylpropanamido]-3-(1H-indol-3-yl)propanamido]-5-carbamimidamidopentanoic acid

C32H45N11O5 (663.3605)


   

Arg Arg Phe Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-5-carbamimidamidopentanamido]-3-phenylpropanamido]-3-(1H-indol-3-yl)propanoic acid

C32H45N11O5 (663.3605)


   

Arg Arg Trp Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-5-carbamimidamidopentanamido]-3-(1H-indol-3-yl)propanamido]-3-phenylpropanoic acid

C32H45N11O5 (663.3605)


   

Arg Trp Phe Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-(1H-indol-3-yl)propanamido]-3-phenylpropanamido]-5-carbamimidamidopentanoic acid

C32H45N11O5 (663.3605)


   

Arg Trp Arg Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-(1H-indol-3-yl)propanamido]-5-carbamimidamidopentanamido]-3-phenylpropanoic acid

C32H45N11O5 (663.3605)


   

Trp Phe Arg Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-phenylpropanamido]-5-carbamimidamidopentanamido]-5-carbamimidamidopentanoic acid

C32H45N11O5 (663.3605)


   

Trp Arg Phe Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-5-carbamimidamidopentanamido]-3-phenylpropanamido]-5-carbamimidamidopentanoic acid

C32H45N11O5 (663.3605)


   

Trp Arg Arg Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-5-carbamimidamidopentanamido]-5-carbamimidamidopentanamido]-3-phenylpropanoic acid

C32H45N11O5 (663.3605)


   

RLNDF

Arg-Leu-Asn-Asp-Phe

C29H45N9O9 (663.334)


   

IFDRN

Ile Phe Asp Arg Asn

C29H45N9O9 (663.334)


   

RVFDK

Arg-Val-Phe-Asp-Lys

C30H49N9O8 (663.3704)


   

PKODiA-PC

1-hexadecanoyl-2-(5-oxo-7-carboxy-6E-heptenoyl)-sn-glycero-3-phosphocholine

C32H58NO11P (663.3747)


   

OHOHA-PS

1-(9Z-octadecenoyl)-2-(4-hydroxy-7-oxo-5E-heptenoyl)-sn-glycero-3-phosphoserine

C31H54NO12P (663.3383)


   

BQ-788 (sodium salt)

BQ-788 (sodium salt)

C34H50N5NaO7 (663.3608)


   

Fmoc-N-amido-PEG8-acid

Fmoc-N-amido-PEG8-acid

C34H49NO12 (663.3255)


   

boc-val-pro-arg-amc hcl

boc-val-pro-arg-amc hcl

C31H46ClN7O7 (663.3147)


   

16-alpha-hydroxygypsogenate-28-beta-D-glucoside

16-alpha-hydroxygypsogenate-28-beta-D-glucoside

C36H55O11- (663.3744)


   

medicagenate-23-O-B-glucoside

medicagenate-23-O-B-glucoside

C36H55O11- (663.3744)


   

[(5R,6E,8E,10E,13S,14R,15R,16Z)-15-hydroxy-5-methoxy-14,16-dimethyl-3-oxo-22-thia-2,24-diazatricyclo[18.6.1.021,25]heptacosa-1(27),6,8,10,16,20,23,25-octaen-13-yl] (2R)-2-(cyclohexanecarbonylamino)propanoate

[(5R,6E,8E,10E,13S,14R,15R,16Z)-15-hydroxy-5-methoxy-14,16-dimethyl-3-oxo-22-thia-2,24-diazatricyclo[18.6.1.021,25]heptacosa-1(27),6,8,10,16,20,23,25-octaen-13-yl] (2R)-2-(cyclohexanecarbonylamino)propanoate

C37H49N3O6S (663.3342)


   

1-Palmitoyl-2-(5-keto-6-octendioyl)-sn-glycero-3-phosphatidylcholine

1-Palmitoyl-2-(5-keto-6-octendioyl)-sn-glycero-3-phosphatidylcholine

C32H58NO11P (663.3747)


   

16alpha-hydroxygypsogenate 28-beta-D-glucoside

16alpha-hydroxygypsogenate 28-beta-D-glucoside

C36H55O11- (663.3744)


   

methyl (1R,6R,9S,13R,16S,22S,23S,26E,27S,28S)-13-ethyl-26-ethylidene-6-hydroxy-2-oxo-21-oxa-17,24,29-triaza-9-azoniaundecacyclo[22.11.2.19,13.123,27.01,22.03,20.05,18.06,16.09,16.022,29.030,35]nonatriaconta-3,5(18),19,30,32,34-hexaene-28-carboxylate

methyl (1R,6R,9S,13R,16S,22S,23S,26E,27S,28S)-13-ethyl-26-ethylidene-6-hydroxy-2-oxo-21-oxa-17,24,29-triaza-9-azoniaundecacyclo[22.11.2.19,13.123,27.01,22.03,20.05,18.06,16.09,16.022,29.030,35]nonatriaconta-3,5(18),19,30,32,34-hexaene-28-carboxylate

C40H47N4O5+ (663.3546)


   

(9Z)-17-hydroxyoctadec-9-enoate 17-O-(6-O-acetyl-beta-D-glucosyl)-(1->2)-beta-D-glucoside

(9Z)-17-hydroxyoctadec-9-enoate 17-O-(6-O-acetyl-beta-D-glucosyl)-(1->2)-beta-D-glucoside

C32H55O14- (663.3592)


   

Lnape 5:0/N-26:7

Lnape 5:0/N-26:7

C36H58NO8P (663.39)


   

Lnape 26:7/N-5:0

Lnape 26:7/N-5:0

C36H58NO8P (663.39)


   

Lnape 24:7/N-7:0

Lnape 24:7/N-7:0

C36H58NO8P (663.39)


   

Lnape 7:0/N-24:7

Lnape 7:0/N-24:7

C36H58NO8P (663.39)


   

(1S,6R,9S,13R,16S,22S,23S,26E,27S,28S)-13-ethyl-26-ethylidene-6-hydroxy-28-methoxycarbonyl-21-oxa-17,29-diaza-9,24-diazoniaundecacyclo[22.11.2.19,13.123,27.01,22.03,20.05,18.06,16.09,16.022,29.030,35]nonatriaconta-2,4,17,19,30,32,34-heptaen-2-olate

(1S,6R,9S,13R,16S,22S,23S,26E,27S,28S)-13-ethyl-26-ethylidene-6-hydroxy-28-methoxycarbonyl-21-oxa-17,29-diaza-9,24-diazoniaundecacyclo[22.11.2.19,13.123,27.01,22.03,20.05,18.06,16.09,16.022,29.030,35]nonatriaconta-2,4,17,19,30,32,34-heptaen-2-olate

C40H47N4O5+ (663.3546)


   

N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyheptadeca-4,8-dien-2-yl]propanamide

N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyheptadeca-4,8-dien-2-yl]propanamide

C32H57NO13 (663.383)


   

N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxypentadeca-4,8-dien-2-yl]pentanamide

N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxypentadeca-4,8-dien-2-yl]pentanamide

C32H57NO13 (663.383)


   

N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxytrideca-4,8-dien-2-yl]heptanamide

N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxytrideca-4,8-dien-2-yl]heptanamide

C32H57NO13 (663.383)


   

N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxydodeca-4,8-dien-2-yl]octanamide

N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxydodeca-4,8-dien-2-yl]octanamide

C32H57NO13 (663.383)


   

N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyoctadeca-4,8-dien-2-yl]acetamide

N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyoctadeca-4,8-dien-2-yl]acetamide

C32H57NO13 (663.383)


   

N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyhexadeca-4,8-dien-2-yl]butanamide

N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyhexadeca-4,8-dien-2-yl]butanamide

C32H57NO13 (663.383)


   

N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxytetradeca-4,8-dien-2-yl]hexanamide

N-[(4E,8E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxytetradeca-4,8-dien-2-yl]hexanamide

C32H57NO13 (663.383)


   

(2S)-2-amino-3-[[3-[(3E,6E,9E)-dodeca-3,6,9-trienoyl]oxy-2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

(2S)-2-amino-3-[[3-[(3E,6E,9E)-dodeca-3,6,9-trienoyl]oxy-2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C34H50NO10P (663.3172)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9E,12E)-pentadeca-9,12-dienoyl]oxypropan-2-yl] (5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9E,12E)-pentadeca-9,12-dienoyl]oxypropan-2-yl] (5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoate

C36H58NO8P (663.39)


   

[3-[(3E,6E,9E)-dodeca-3,6,9-trienoyl]oxy-2-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-[(3E,6E,9E)-dodeca-3,6,9-trienoyl]oxy-2-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C36H58NO8P (663.39)


   

[3-[(6E,9E)-dodeca-6,9-dienoyl]oxy-2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-[(6E,9E)-dodeca-6,9-dienoyl]oxy-2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C36H58NO8P (663.39)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(6E,9E,12E)-pentadeca-6,9,12-trienoyl]oxypropan-2-yl] (7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(6E,9E,12E)-pentadeca-6,9,12-trienoyl]oxypropan-2-yl] (7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoate

C36H58NO8P (663.39)


   

1-Palmitoyl-2-(5-keto-6-octenedioyl)-sn-glycero-3-phosphocholine

1-Palmitoyl-2-(5-keto-6-octendioyl)-sn-glycero-3-phosphatidylcholine

C32H58NO11P (663.3747)


   

PC(28:7)

PC(18:3_10:4)

C36H58NO8P (663.39)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

ST 26:5;O7;HexNAc

ST 26:5;O7;HexNAc

C34H49NO12 (663.3255)


   

ST 27:4;O6;HexNAc

ST 27:4;O6;HexNAc

C35H53NO11 (663.3618)


   

ST 28:3;O5;HexNAc

ST 28:3;O5;HexNAc

C36H57NO10 (663.3982)


   

5,8,17,20-tetrahydroxy-3-(1h-indol-3-ylmethyl)-6,15-bis(2-methylpropyl)-1,4,7,13,16,19-hexaazatricyclo[19.3.0.0⁹,¹³]tetracosa-4,7,16,19-tetraene-2,14-dione

5,8,17,20-tetrahydroxy-3-(1h-indol-3-ylmethyl)-6,15-bis(2-methylpropyl)-1,4,7,13,16,19-hexaazatricyclo[19.3.0.0⁹,¹³]tetracosa-4,7,16,19-tetraene-2,14-dione

C35H49N7O6 (663.3744)


   

2-amino-3-({15-[(1r,7r)-7-[(5e)-7-ethoxy-7-oxohept-5-en-1-yl]-2-hydroxy-6,8-dioxabicyclo[3.2.1]octan-5-yl]pentadecyl}oxy)propoxysulfonic acid

2-amino-3-({15-[(1r,7r)-7-[(5e)-7-ethoxy-7-oxohept-5-en-1-yl]-2-hydroxy-6,8-dioxabicyclo[3.2.1]octan-5-yl]pentadecyl}oxy)propoxysulfonic acid

C33H61NO10S (663.4016)


   

5,8,17,20-tetrahydroxy-3-(1h-indol-3-ylmethyl)-6,15-bis(sec-butyl)-1,4,7,13,16,19-hexaazatricyclo[19.3.0.0⁹,¹³]tetracosa-4,7,16,19-tetraene-2,14-dione

5,8,17,20-tetrahydroxy-3-(1h-indol-3-ylmethyl)-6,15-bis(sec-butyl)-1,4,7,13,16,19-hexaazatricyclo[19.3.0.0⁹,¹³]tetracosa-4,7,16,19-tetraene-2,14-dione

C35H49N7O6 (663.3744)


   

(3s,6s,9s,15s,21s)-5,8,17,20-tetrahydroxy-3-(1h-indol-3-ylmethyl)-6,15-bis(2-methylpropyl)-1,4,7,13,16,19-hexaazatricyclo[19.3.0.0⁹,¹³]tetracosa-4,7,16,19-tetraene-2,14-dione

(3s,6s,9s,15s,21s)-5,8,17,20-tetrahydroxy-3-(1h-indol-3-ylmethyl)-6,15-bis(2-methylpropyl)-1,4,7,13,16,19-hexaazatricyclo[19.3.0.0⁹,¹³]tetracosa-4,7,16,19-tetraene-2,14-dione

C35H49N7O6 (663.3744)


   

2-[2-({17-amino-6-[(3,4-dicarboxybutanoyl)oxy]-14,16-dihydroxy-5,9-dimethylheptadecan-7-yl}oxy)-2-oxoethyl]butanedioic acid

2-[2-({17-amino-6-[(3,4-dicarboxybutanoyl)oxy]-14,16-dihydroxy-5,9-dimethylheptadecan-7-yl}oxy)-2-oxoethyl]butanedioic acid

C31H53NO14 (663.3466)


   

2-[2-(6-{[(4ar,8s,11r,14s)-9,12-dihydroxy-14-methyl-11-(2-methylpropyl)-5,15-dioxo-1h,2h,3h,4h,4ah,7h,8h,11h,14h-pyridazino[3,2-c]1-oxa-4,7,10-triazacyclotridecan-8-yl]-c-hydroxycarbonimidoyl}-5,6-dihydro-4h-pyridazin-1-yl)-2-oxoethyl]heptanoic acid

2-[2-(6-{[(4ar,8s,11r,14s)-9,12-dihydroxy-14-methyl-11-(2-methylpropyl)-5,15-dioxo-1h,2h,3h,4h,4ah,7h,8h,11h,14h-pyridazino[3,2-c]1-oxa-4,7,10-triazacyclotridecan-8-yl]-c-hydroxycarbonimidoyl}-5,6-dihydro-4h-pyridazin-1-yl)-2-oxoethyl]heptanoic acid

C31H49N7O9 (663.3592)


   

(1r,2s,3s,7s,10r,13r,14s,15r,17r,18r,19r)-8,15,17,18-tetrahydroxy-3,19-dimethoxy-2,14,18-trimethyl-10-(2-methylpropyl)-7-[2-(methylsulfanyl)ethyl]-13-propyl-6,12,21-trioxa-9-azabicyclo[15.3.1]henicos-8-ene-5,11-dione

(1r,2s,3s,7s,10r,13r,14s,15r,17r,18r,19r)-8,15,17,18-tetrahydroxy-3,19-dimethoxy-2,14,18-trimethyl-10-(2-methylpropyl)-7-[2-(methylsulfanyl)ethyl]-13-propyl-6,12,21-trioxa-9-azabicyclo[15.3.1]henicos-8-ene-5,11-dione

C32H57NO11S (663.3652)


   

(3r,6s,9s,15s,21s)-6,15-bis[(2s)-butan-2-yl]-5,8,17,20-tetrahydroxy-3-(1h-indol-3-ylmethyl)-1,4,7,13,16,19-hexaazatricyclo[19.3.0.0⁹,¹³]tetracosa-4,7,16,19-tetraene-2,14-dione

(3r,6s,9s,15s,21s)-6,15-bis[(2s)-butan-2-yl]-5,8,17,20-tetrahydroxy-3-(1h-indol-3-ylmethyl)-1,4,7,13,16,19-hexaazatricyclo[19.3.0.0⁹,¹³]tetracosa-4,7,16,19-tetraene-2,14-dione

C35H49N7O6 (663.3744)